Connect with us
Esteve has expanded internationally by acquiring HRA Pharma Rare Diseases from Perrigo Company plc, adding three drugs for treating Cushing's syndrome and adrenocortical carcinoma. This €275...
Spanish biotech company Viva in Vitro, led by Toni Vilaplana, has raised over €1.3 million in its latest funding round, totaling over €3.2 million in three...
Nick Oberheiden's steadfast commitment to excellence and tireless pursuit of fair outcomes underscores his pivotal role in shaping the landscape of healthcare litigation. His advocacy not...
Grifols can modify its complaint until September 9 or notify by August 13 if it will maintain it. Gotham has until September 12 to respond, Grifols...
Valued at €2.4 million, Dipneo will use funds to finalize its commercial prototype and begin regulatory procedures. The autonomous, hands-free device inflates air into patients and...
Various investors, including SoftBank Vision, Apollo, OrbiMed, Tencent, and RA Capital Management, are funding oncology research and innovation. Collectively, investments in the sector exceed $17 billion,...
96% of the biotech companies are SMEs or micro-SMEs, contributing minimally to the Spanish biotech sector revenues. Large firms, though only 4.1%, account for 37.9% of...
Veeva is expanding in Spain, adding 30 new positions to its current 300 employees. This follows the opening of its European headquarters in Barcelona and hosting...
Biotest, a Grifols group company, expects $1 billion in US sales of its immunoglobulin drug Yimmugo over the next seven years, following FDA approval. Grifols shares...
Grifols and PharmaMar significantly dropped Spanish pharmaceutical stocks, with declines of 49.1% and 22.5% respectively in the first half of 2024. Although other companies like Rovi...
 |
|
 |  |
 |
|